← Leaderboards
Barry M Trost
University Of California San Francisco
$12,485,921
Attributed
$12,485,921
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$12,485,921 · 12
By mechanism
R01$11,800,980 · 2
P41$684,941 · 10
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Palladium”
- John F Hartwig · University Of California Berkeley$12,202,703
- Stephen L Buchwald · Massachusetts Institute Of Technology$11,783,158
- Sergey A Kozmin · University Of Chicago$9,892,654
- Kristy Perez · Civatech Oncology, Inc.$9,817,743
- Brian M Stoltz · California Institute Of Technology$7,409,940
- Maria Christina White · Harvard University$5,908,255
Research focus
PalladiumAlkynesAntiviral AgentsAlkylationDesignStereochemistryBiologicalCatalystAlkenesReactionMetalsReagentLeadStructureComplexBaseInsightCouplingMemberMethodologyDrug Design /Synthesis /ProductionFamilyMolecularTranslating
Grant awards (44)
Novel Approaches for Antitumor and Antiviral Agents$390,795
R01 · FY2016 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$389,541
R01 · FY2015 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$388,323
R01 · FY2014 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$381,442
R01 · FY2013 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$420,177
R01 · FY2012 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$419,053
R01 · FY2011 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$425,560
R01 · FY2010 · GM · contact PI
Synthesis of Macrolides, Steroids, Cyclopentanoids, etc.$590,251
R01 · FY2009 · GM · contact PI
Novel Approaches for Antitumor and Antiviral Agents$449,357
R01 · FY2009 · GM · contact PI
Synthesis of Macrolides, Steroids, Cyclopentanoids, etc.$588,962
R01 · FY2008 · GM · contact PI
Novel Approaches to Antitumor and Antiviral Agents$341,135
R01 · FY2008 · GM · contact PI
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS:$46,911
P41 · FY2008 · RR · contact PI
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS$45,361
P41 · FY2008 · RR · contact PI
Synthesis of Macrolides, Steroids, Cyclopentanoids, etc.$522,571
R01 · FY2007 · GM · contact PI
Novel Approaches to Antitumor and Antiviral Agents$341,519
R01 · FY2007 · GM · contact PI
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRALS, HIV$193,624
P41 · FY2007 · RR · contact PI
Synthesis of Macrolides, Steroids, Cyclopentanoids, etc.$82,693
R01 · FY2007 · GM · contact PI
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS$66,067
P41 · FY2007 · RR · contact PI
Synthesis of Macrolides, Steroids, Cyclopentanoids, etc.$569,086
R01 · FY2006 · GM · contact PI
Novel Approaches to Antitumor and Antiviral Agents$361,447
R01 · FY2006 · GM · contact PI
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV$33,923
P41 · FY2006 · RR · contact PI
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS$30,295
P41 · FY2006 · RR · contact PI
Synthesis of Macrolides. Steroids, Cyclopentanoids, etc$537,542
R01 · FY2005 · GM
Novel Approaches to Antitumor and Antiviral Agents$366,006
R01 · FY2005 · GM
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV$57,206
P41 · FY2005 · RR
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS$26,787
P41 · FY2005 · RR
Synthesis of Macrolides. Steroids, Cyclopentanoids, etc$524,128
R01 · FY2004 · GM
Novel Approaches to Antitumor and Antiviral Agents$386,074
R01 · FY2004 · GM
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV$129,246
P41 · FY2004 · RR
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS$35,761
P41 · FY2004 · RR
Synthesis of Macrolides. Steroids, Cyclopentanoids, etc$519,106
R01 · FY2003 · GM
Novel Approaches to Antitumor and Antiviral Agents$375,037
R01 · FY2003 · GM
Synthesis of Macrolides. Steroids, Cyclopentanoids, etc$521,769
R01 · FY2002 · GM
Novel Approaches to Antitumor and Antiviral Agents$364,322
R01 · FY2002 · GM
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC: SYNTHETIC DESIGNS$0
P41 · FY2002 · RR
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: HIV$0
P41 · FY2002 · RR
SYNTHESIS OF MACROCYCLES STEROIDS CYCLOPENTANOIDS ETC$443,079
R01 · FY2001 · GM
Novel Approaches to Antitumor and Antiviral Agents$380,569
R01 · FY2001 · GM
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC: SYNTHETIC DESIGNS$0
P41 · FY2001 · RR
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: HIV$0
P41 · FY2001 · RR
SYNTHESIS OF MACROCYCLES STEROIDS CYCLOPENTANOIDS ETC$432,932
R01 · FY2000 · GM
NOVEL APPROACHES TO ANTITUMOR AND ANTIVIRAL AGENTS$288,504
R01 · FY2000 · GM
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: HIV$9,880
P41 · FY2000 · RR
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC: SYNTHETIC DESIGNS$9,880
P41 · FY2000 · RR